LOGIN  |  REGISTER
Cue Biopharma

U.S. Physical Therapy Schedules First Quarter 2023 Earnings Release and Conference Call

April 19, 2023 | Last Trade: US$84.56 2.22 -2.56

HOUSTON / Apr 19, 2023 / Business Wire / U.S. Physical Therapy, Inc. (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the first quarter ended March 31, 2023 on Wednesday, May 3, 2023, after the stock market closes, with the conference call to follow the next morning, on Thursday, May 4, 2023.

Conference Call

 

Date:

Thursday, May 4, 2023

 

 

Time:

10:30 am Eastern/9:30 am Central

 

 

Dial-In Number:

(800) 895-3361 Primary or

 

 

 

(785) 424-1062 Alternate

 

 

Conference ID:

USPHQ123

 

 

(In order to join this conference call,

 

 

you will be required to provide the Conference ID listed above)

 

 

 

 

To participate, please call in 10 minutes prior to start time.

To listen to the live call, please go to www.usph.com and click on conference calls under the Investor Relations section. Please go to the website 15 minutes early to register, download and install any necessary audio software. If you are unable to listen live, a playback of the conference call can be accessed until August 4, 2023 at U.S. Physical Therapy’s website.

About U.S. Physical Therapy, Inc.

Founded in 1990, U.S. Physical Therapy, Inc. operates 647 outpatient physical therapy clinics in 40 states. The Company's clinics provide preventative and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, treatment for neurologically-related injuries and rehabilitation of injured workers. In addition to owning and operating clinics, the Company manages 36 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups. The Company also has an industrial injury prevention services business which provides onsite services for clients’ employees including injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments.

More information about U.S. Physical Therapy, Inc. is available at www.usph.com The information included on that website is not incorporated into this press release.

Recursion

Stock Quote

Featured Stock

Surmodics

Surmodics is the global leader in surface modification technologies for intravascular medical devices and a leading provider of chemical components for in vitro diagnostic immunoassay tests and microarrays. Surmodics is pursuing highly differentiated whole-product solutions that are designed to address...

CLICK TO LEARN MORE

Featured Stock

C4 Therapeutics

C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB